Motilal Oswal Unlocks 3 Top Stocks: Massive 30% Upside Potential Revealed!

BROKERAGE-REPORTS
Whalesbook Logo
AuthorSimar Singh|Published at:
Motilal Oswal Unlocks 3 Top Stocks: Massive 30% Upside Potential Revealed!
Overview

Brokerage firm Motilal Oswal has identified three stocks – GAIL, Privi Speciality Chemicals, and Global Health – with a potential upside of 17-30% over the next few years. The firm has issued 'Buy' ratings and set specific target prices, citing growth drivers, capacity expansions, and market recovery for each company.

Motilal Oswal Identifies High-Potential Stocks

Brokerage firm Motilal Oswal has highlighted three select stocks that it believes are poised for significant returns, offering investors an upside potential ranging from 17% to 30% over the coming years. These recommendations are based on detailed analysis of company growth, industry trends, and specific business developments.

GAIL (India) Ltd: Recovery and Growth Ahead

Motilal Oswal has reiterated its 'Buy' rating on GAIL (India) Ltd with a target price of Rs 220, suggesting a potential 25% upside. The brokerage expects a recovery in the stock, supported by improving gas demand and enhanced profitability across key business segments.

  • Volume Growth: Natural gas transmission volumes are projected to rise from 123 mmscmd in FY26 to 132 mmscmd by FY28.
  • Petrochemicals: The petrochemical division is anticipated to perform better as new capacities become operational, with potential stabilization in spreads.
  • Tariff Impact: Revised transmission tariffs, effective January 2026, are expected to boost FY27 estimated Profit After Tax by approximately 7%.
  • Demand Recovery: Anticipated demand resurgence from major sectors like power and fertiliser, alongside government reforms in natural gas taxation, supports the positive outlook.

Privi Speciality Chemicals Ltd: Expansion and Diversification

Motilal Oswal has initiated coverage on Privi Speciality Chemicals with a 'Buy' rating and a target price of Rs 3,960, implying nearly 30% upside. The brokerage foresees strong growth driven by capacity expansion, product diversification, and deepening customer relationships.

  • Growth Projections: Expected Compound Annual Growth Rate (CAGR) of 27% in revenue and 34% in EBITDA over FY25-28.
  • Capacity Expansion: Core product capacity will increase from 48,000 tonnes to 66,000 tonnes by March 2028. Additional capacity for new products is planned.
  • Customer Synergies: A joint venture with Givaudan enhances technological capabilities and integration into global fragrance ingredient supply chains.
  • Financial Performance: Reported a revenue/EBITDA/adjusted PAT CAGR of 14%/32%/24% over FY22-25.

Global Health Ltd: Expanding Healthcare Network

Motilal Oswal maintains its 'Buy' call on Global Health, operator of the Medanta hospital chain, setting a target price of Rs 1,480, indicating an approximate 17% upside. The brokerage highlights the strategic importance of the new Noida hospital and ongoing expansion plans.

  • Noida Facility: The new hospital in Noida is expected to achieve EBITDA breakeven within 12-15 months, catering to a wide patient radius.
  • Network Support: The broader network, including facilities in Gurugram, Lucknow, and other cities, is expected to bolster overall earnings post-breakeven.
  • Future Growth: Expansion projects in Mumbai, Guwahati, and other regions provide sustained growth visibility for the coming years.

Impact

These stock recommendations from a prominent brokerage firm can influence investor sentiment and trading activity for GAIL, Privi Speciality Chemicals, and Global Health. Investors might consider these insights for portfolio adjustments, potentially leading to increased buying or selling pressure on these stocks. The detailed rationale provided by Motilal Oswal offers investors a clearer understanding of the potential risks and rewards associated with each company.

  • Impact Rating: 7/10

Difficult Terms Explained

  • mmscmd: Million metric standard cubic meters per day. A unit to measure the volume of natural gas.
  • PAT: Profit After Tax. The profit a company has left after deducting all taxes.
  • CAGR: Compound Annual Growth Rate. The average annual growth rate of an investment over a specified period of time.
  • EBITDA: Earnings Before Interest, Tax, Depreciation, and Amortisation. A measure of a company's operating performance.
  • TAM: Total Addressable Market. The total market demand for a product or service.
  • Spread: The difference between the selling price and the cost price of a product, often used in commodity trading or manufacturing.
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.